![]() |
市場調查報告書
商品編碼
2141394
蛋白質水解物在老年營養領域的市場機會、成長要素、產業趨勢分析及2026-2035年預測Geriatric Nutrition Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
預計到 2025 年,全球用於老年人營養的水解蛋白市場規模將達到 4.44 億美元,年複合成長率為 7.6%,到 2035 年將達到 9.21 億美元。
| 市場範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測期 | 2026-2035 |
| 初始市場規模 | 4.44億美元 |
| 預計金額 | 9.21億美元 |
| 複合年成長率 | 7.6% |
蛋白質水解物是透過酶解、酸處理或鹼處理將蛋白質轉化為較短的肽鍊或遊離氨基酸而製成的。它們在老年營養領域的價值不僅限於提供蛋白質;其獨特的結構使其能夠更快地被吸收,同時減輕消化負擔。這些特性使得水解蛋白在專為老年人開發的營養產品中特別重要,這些老年人面臨胃腸道功能衰退、吸收不良、食慾不振或肌肉萎縮等高風險。隨著人口老化和營養需求日益多樣化,人們對具有更高耐受性和吸收率以及有效補充蛋白質的配方需求不斷成長。因此,製造商正致力於開發基於水解物的營養解決方案,以應對與老齡化相關的生理挑戰。人們對維持營養狀況和肌肉健康的日益關注也推動了臨床和家庭營養護理中對特殊蛋白質來源的需求。
預計到2025年,動物源蛋白水解物市場規模將達到3.15億美元,並在2035年之前以6.8%的複合年成長率成長。在這個市場中,牛奶和酪蛋白水解物是最大的類別,其次是乳清蛋白水解物。動物源蛋白成熟的營養成分和功能特性使其繼續在老年人專用營養配方中得到應用。生產商可以進一步將這些蛋白質來源加工成水解物,以增強其對特定消化和營養需求產品的適用性。
預計到2025年,臨床營養市場規模將達2億美元。醫院營養計畫和腸內營養產品是其主要應用領域,因為胃腸功能衰退和吸收不良可能會增加對水解蛋白製劑的需求。歐洲腸外腸內營養學會(ESPEN)指南將適當的蛋白質補充與老年人的營養護理聯繫起來,進一步推動了旨在提高耐受性和有效吸收的配方的發展。因此,能夠應對與老齡化和消化功能衰退相關的飲食挑戰的專業營養解決方案的需求,進一步推動了對臨床營養產品的需求。
預計到2025年,北美老年營養用水解蛋白市場規模將達到1.46億美元,並在2035年之前以6.6%的複合年成長率成長。美國是該地區領先的市場,這得益於醫院營養支持團隊、完善的家庭經腸營養系統以及消費者營養補充劑的廣泛普及。這些多元化的分銷管道使製造商能夠觸及機構和居家照護環境中的老年消費者。加拿大在機構臨床營養領域也產生了額外的需求,但由於其在該地區相對較高的市場滲透率,預計其成長速度將比新興市場更為溫和。
The Global Geriatric Nutrition Protein Hydrolysates Market was valued at USD 444 million in 2025 and is estimated to grow at a CAGR of 7.6% to reach USD 921 million by 2035.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $444 Million |
| Forecast Value | $921 Million |
| CAGR | 7.6% |
Protein hydrolysates are produced by converting proteins into shorter peptide chains and free amino acids through enzymatic, acid, or alkaline processing. Their value in geriatric nutrition extends beyond delivering protein because their structure can support faster absorption while reducing digestive demands. These characteristics make hydrolyzed protein particularly relevant to nutritional products developed for older adults experiencing gastrointestinal impairment, malabsorption, reduced appetite, or an elevated risk of muscle loss. As aging populations increase and nutritional requirements become more specialized, demand is shifting toward formulations that can provide effective protein support with improved tolerance and absorption. Manufacturers are consequently focusing on hydrolysate-based nutritional solutions that address the physiological challenges associated with aging. The growing emphasis on maintaining nutritional status and supporting muscle health is also creating opportunities for specialized protein ingredients across clinical and home-based nutrition settings.
Animal-based protein hydrolysates segment accounted for USD 315 million in 2025 and is forecast to grow at a CAGR of 6.8% through 2035. Milk and casein hydrolysates represent the largest category within this segment, while whey protein hydrolysates rank next. The established nutritional profiles and functional characteristics of animal-derived proteins continue to support their use in specialized geriatric nutrition formulations. Manufacturers can further process these protein sources into hydrolysates to improve their suitability for products designed around specific digestive and nutritional requirements.
Clinical nutrition segment held USD 200 million in 2025. Hospital nutrition programs and tube-feeding products represent the dominant areas of use, as gastrointestinal impairment and malabsorption can increase the need for hydrolyzed protein formulations. ESPEN guidance connects adequate protein support with nutritional care for older adults, providing additional support for formulas designed to promote tolerance and efficient absorption. Demand for clinical nutrition products is therefore being reinforced by the need for specialized nutritional solutions that can address the dietary challenges associated with aging and compromised digestive function.
North America Geriatric Nutrition Protein Hydrolysates Market captured USD 146 million in 2025 and is forecast to grow at a CAGR of 6.6% through 2035. The United States serves as the region's primary market, supported by hospital-based nutrition support teams, established homecare enteral nutrition systems, and broad access to direct-to-consumer supplements. These multiple distribution channels allow manufacturers to reach older consumers across institutional and home-based care environments. Canada contributes additional demand from institutional clinical nutrition, although the region's relatively high market penetration is expected to moderate its growth rate compared with less-developed markets.
Major companies participating in the global geriatric nutrition protein hydrolysates market include Fonterra, Nestle Health Science, Arla Foods Ingredients, Royal FrieslandCampina, and Kerry Group. Companies in the global geriatric nutrition protein hydrolysates market are strengthening their market foothold through product innovation, portfolio expansion, clinical nutrition partnerships, and improvements in formulation technology. Leading participants are developing hydrolysates with targeted peptide profiles to support digestibility, absorption, and nutritional tolerance among older consumers. Companies are also expanding their protein portfolios across milk, casein, and whey sources to address diverse formulation requirements. Partnerships with healthcare providers, nutrition specialists, and institutional care channels can help manufacturers expand product adoption and strengthen market access. Investments in research and development enable suppliers to improve formulation performance while responding to evolving geriatric nutrition needs. Companies are also increasing distribution through homecare and consumer channels to reach broader customer groups. By combining specialized product development, quality improvements, expanded distribution networks, and stronger relationships across clinical nutrition channels, market participants are positioning themselves to capture growing demand for protein hydrolysate solutions in geriatric care.